812c Filgotinib (GLPG0634), an Oral JAK1 Selective Inhibitor, Induces Clinical Remission in Patients With Moderate-to-Severe Crohn's Disease: Results From the Phase 2 FITZROY Study Interim Analysis - Vermeire, Severine; Schreiber, Stefan; Petryka, Robert; Kuehbacher, Tanja; Hebuterne, Xavier; Roblin, Xavier; Klopocka, Maria; Goldis, Adrian; Wisniewska-Jarosinska, Maria A.; Baranovsky, Andrei; Sike, Robert; Tasset, Chantal T.; et al. (Gastroenterology (New York, N.Y. 1943), 2016)